SCHEMBL31428835

SCHEMBL31428835

CC(=O)N1C(=Cc2cc(C(=O)N3CCN(C4COC4)CC3)c3ccccc3n2)C(=O)c2ccccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
ALDH1A1 P00352 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
TSHR P16473 2/20 0.39
HTT P42858 2/20 0.39
LMNA P02545 2/20 0.39
MAPT P10636 1/20 0.39
MAPK1 P28482 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
KDM4E B2RXH2 4/20 0.38
HPGD P15428 2/20 0.38
HSD17B10 Q99714 2/20 0.38
USP2 O75604 1/20 0.38
TP53 P04637 1/20 0.38
CYP2C9 P11712 3/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
MOK Q9UQ07 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31428704 0.88 ALDH1A1 (0.52) POLBMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL31428701 0.86 ALDH1A1 (0.35) ALDH1A1SMN1; SMN2HTTLMNAMAPT
SCHEMBL31429054 0.85 LRRK2 (0.34) ALDH1A1SMN1; SMN2HTTLMNAMAPT
SCHEMBL31428613 0.85 PDCD1 (0.38) ALDH1A1SMN1; SMN2HTTMAPTMAPK1
SCHEMBL31428635 0.85 PDCD1 (0.38) ALDH1A1SMN1; SMN2HTTMAPTMAPK1
SCHEMBL31428556 0.84 PDCD1 (0.37) ALDH1A1SMN1; SMN2HTTMAPTMAPK1
SCHEMBL31428674 0.84 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2TSHRHTTMAPT
SCHEMBL31428450 0.84 ACACB (0.34) ALDH1A1SMN1; SMN2TSHRHTTLMNA
SCHEMBL31428769 0.82 LRRK2 (0.34) MEN1KMT2AALDH1A1SMN1; SMN2HTT
SCHEMBL31428694 0.79 ALDH1A1 (0.49) POLBMEN1KMT2AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250091994-A1 RAS/RAF BINDING INHIBITOR COMPOUND NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) 2025-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250091994-A1 RAS/RAF BINDING INHIBITOR COMPOUND BRAF, RAF1, NRAS POLB 3285/4885MEN1 1712/4885KMT2A 2837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.